Surgical Science Sweden AB (publ)

OTCPK:SUSR.F Stock Report

Market Cap: US$659.9m

Surgical Science Sweden Past Earnings Performance

Past criteria checks 2/6

Surgical Science Sweden has been growing earnings at an average annual rate of 61.1%, while the Medical Equipment industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 50.8% per year. Surgical Science Sweden's return on equity is 4.5%, and it has net margins of 24.7%.

Key information

61.1%

Earnings growth rate

56.7%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate50.8%
Return on equity4.5%
Net Margin24.7%
Next Earnings Update22 Aug 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Surgical Science Sweden makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:SUSR.F Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24842208233181
31 Dec 23883234240182
30 Sep 23906253230182
30 Jun 23901234222185
31 Mar 23872221215179
31 Dec 22803188202173
30 Sep 22750138200159
30 Jun 22640124176130
31 Mar 2248910114697
31 Dec 213678611766
30 Sep 21209307637
30 Jun 21138216026
31 Mar 21122185320
31 Dec 20105165017
30 Sep 20104145118
30 Jun 20112195419
31 Mar 20107175219
31 Dec 19102135117
30 Sep 198864915
30 Jun 1970-54313
31 Mar 1968-54313
31 Dec 1866-53914
30 Sep 1860-33810
30 Jun 1857-6377
31 Mar 1856-7344
31 Dec 1757-3310
30 Sep 17654300
30 Jun 17603270
31 Mar 17594270
31 Dec 16583290
31 Dec 15522240
31 Dec 1441-3210

Quality Earnings: SUSR.F has high quality earnings.

Growing Profit Margin: SUSR.F's current net profit margins (24.7%) are lower than last year (25.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SUSR.F has become profitable over the past 5 years, growing earnings by 61.1% per year.

Accelerating Growth: SUSR.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: SUSR.F had negative earnings growth (-6%) over the past year, making it difficult to compare to the Medical Equipment industry average (2.6%).


Return on Equity

High ROE: SUSR.F's Return on Equity (4.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.